Thiazolidine compounds in the treatment of anemic conditions

Details Thiazolidine compounds in the treatment of anemic conditions Thiazolidine compounds in the treatment of anemic conditions

C - Chemistry, Metallurgy

07

D

C07D 417/08 (2006.01) A61K 31/42 (2006.01) A61K 31/4427 (2006.01) A61K 31/47 (2006.01) A61P 7/04 (2006.01) A61P 7/06 (2006.01) C07D 277/20 (2006.01) C07D 417/06 (2006.01) C07D 417/10 (2006.01) C07D 417/14 (2006.01) C07D 471/04 (2006.01)

Patent

CA 2507256

This invention relates to newly identified compounds for inhibiting Hyak3 proteins and methods for treating diseases associated with the imbalance or inappropriate activity of Hyak3 proteins.

La présente invention concerne des composés récemment identifiés permettant d'inhiber les protéines Hyak3, ainsi que des méthodes permettant de traiter des maladies associées à l'activité déséquilibrée ou inappropriée des protéines Hyak3.

Affiliated with

Also associated with

Rating

Thiazolidine compounds in the treatment of anemic conditions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Thiazolidine compounds in the treatment of anemic conditions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiazolidine compounds in the treatment of anemic conditions will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1859034